APOE and atherosclerosis: Previous study showed that the small-molecule compounds targeting farnesyl transferase have the ability to prevent atherosclerosis in apolipoprotein E-deficient mice, as evidenced by reduced fatty streak lesion size, decreased smooth muscle-like cell accumulation in the neointima and ameliorated oxidative stress[7].